Approximately 4% of all patients with pancreatic ductal adenocarcinoma have an underlying gene defect, with ATM, BRCA1/2, and PALB2 being the most commonly affected genes [23,24,25]. This evidence concerns the gene BRCA1 and pancreatic ductal adenocarcinoma.